视网醇结合蛋白1型表达预测头部和部状细胞癌的预后不佳
Ling-Ling Fu1,2, Ming Yan1,2, Xin Yu1
1Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, 050017, PR China.
BMC cancer
|October 15, 2024
概括
视网醇结合蛋白1 (RBP1) 在头部和部状细胞癌 (HNSCC) 中过度表达,这表明它是患者预后不佳的重要标志物. 这一发现对于理解HNSCC进展至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 头部和部状细胞癌 (HNSCC) 是一种普遍存在的恶性瘤,存活率较低.
- 视网醇结合蛋白1 (RBP1) 与各种癌症有关,并可能作为预后因素.
- RBP1和HNSCC之间的关系需要使用全面的数据库进行进一步的调查.
研究的目的:
- 分析HNSCC中RBP1的表达水平和预后值.
- 调查RBP1甲基化与患者结局之间的相关性.
- 探索RBP1在HNSCC中的潜在生物功能.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库用于RBP1表达和临床数据.
- 在患者组织上进行定量PCR,以评估RBP1mRNA水平.
- 使用考克斯回归,名录分析,UALACN,MethSurv,GSEA和ssGSEA来评估RBP1的预后和功能作用.
主要成果:
- 与正常组织相比,HNSCC组织中的RBP1mRNA表达显著升高.
- 高RBP1表达是HNSCC患者预后不佳的独立指标 (P<0.05).
- 在HNSCC中,RBP1甲基化增加,并且与特定的CpG部位的更好的预后相关;RBP1表达与免疫细胞透和检查点有轻微的关联.
结论:
- 在头部和部状细胞癌中,RBP1过度表达.
- 升高的RBP1水平与患者预后不佳显著相关.
- RBP1 作为 HNSCC 的潜在预后生物标志物.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


